We are thrilled to announce another #winner of the #PropellingGrant – Congrats to the innovators from MirEndo Jacopo Millul, PhD & Melpomeni Fani from the University of Basel & Universitätsspital Basel (USB)!
MirEndo convinced the selection committee with cutting-edge technology to diagnose endometriosis through high-precision radiopharmaceuticals and positron emission tomography scans. Some time ago, we sat down with MirEndo and asked them some questions! Read the interview here:
𝗤: 𝗖𝗮𝗻 𝘆𝗼𝘂 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲 𝘄𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗠𝗶𝗿𝗘𝗻𝗱𝗼 𝘄𝗮𝗻𝘁𝘀 𝘁𝗼 𝘁𝗮𝗰𝗸𝗹𝗲?
Endometriosis affects 1 in 10 women in the world. Nevertheless, no specific diagnostic exists. For this reason, patients consult different gynaecologists during their lives, and the official diagnosis (possible only with an invasive surgical procedure) comes 7-10 years after the first symptoms occur. Altogether, this patient journey has an economic impact of about 120 billion USD/year. With MirEndo, we are aiming to shorten this journey from years to a few months, by providing a reliable and fast diagnostic and staging solution for endometriosis.
𝗤: 𝗛𝗼𝘄 𝗶𝘀 𝘁𝗵𝗲 𝗣𝗿𝗼𝗽𝗲𝗹𝗹𝗶𝗻𝗴 𝗚𝗿𝗮𝗻𝘁 𝗵𝗲𝗹𝗽𝗶𝗻𝗴 𝘆𝗼𝘂 𝘁𝗼 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝘆𝗼𝘂𝗿 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗹𝗼𝗻𝗴 𝘆𝗼𝘂𝗿 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝗶𝗮𝗹 𝗷𝗼𝘂𝗿𝗻𝗲𝘆?
The #PropellingGrant from the University of Basel will support the development of MirEndo by providing support on specific needs, such as mentoring and skill-building. The visibility offered by the Innovation Office will expand the network and allow future collaborations, helping MirEndo grow its way to become a successful start-up.
Are you curious about the next #PropellingGrant? – then have a look below!